 |
| Women's Clinical Research Center |
|
|
|
|
|
|
Lakeview Medical Dental Building |
IN
THEIR OWN WORDS ON MENOPAUSE AND DECREASED SEX DRIVE Dr. Robin Kroll, a Seattle gynecologist, is a lead investigator for a study funded by Procter & Gamble Pharmaceuticals measuring the effectiveness of the company's testosterone skin patch for women, which has not yet been approved by the Food and Drug Administration: "As women age, their testosterone levels fall. One of the hallmarks of decreased testosterone levels in women is a loss of sexual desire. We've already done clinical trials (of the patch) looking at women who are taking hormone replacement therapy (the findings of this study will be announced next month). Since the Women's Health Initiative, lots of women have chosen to go off their hormones or declined to start hormones. Because of that, we've decided to look at menopausal women with low sexual desire who aren't taking hormone replacement therapy. The question we're trying to answer is: Will women respond as well to the patch alone if they have not replenished the estrogen lost during menopause? These doses are replacement doses. We're not trying to give women male levels of testosterone; we're trying to give them female levels." AROUND THE SOUND: HEALTH
|
|
||
|